Dong-A Pharmaceutical names new execs in shake-up

Published: 2010-11-29 06:57:00

Updated: 2010-11-29 06:57:00

Dong-A Pharmaceutical Co. says it has appointed Kang Jeong-seok, vice president and the forth son of incumbent Chairman Kang Shin-ho, as executive vice president to take charge of R&D functions in addition to overall management administration in a management reshuffle which involved several execu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK